News Search

With funding from the Advanced Research Projects Agency for Health (ARPA-H), Columbia scientists will lead development of genetic tests to diagnose congenital defects in the lymphatic system.

A drug developed at Columbia saved the life of the first child to receive the therapy and has now been approved by the FDA for use in hundreds of other children with the same rare disease.

Columbia researchers have found that accidental drug overdose, homicide, and suicide are the top causes of death among pregnant and postpartum women.

The funding will support Columbia's mobile dental van, which brings preventive and restorative dental services directly to public schools and Head Start programs in underserved communities.